A team of investigators co-led by Cedars-Sinai Health Sciences University has identified an enzyme that helps prevent the most common form of liver disease from progressing toward liver failure. Results of the preclinical study, published in Nature Metabolism, could point the way to new approaches for preventing serious organ damage.